Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway-Reference-Cited by-同舟云学术

Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway

Published:2018-09 Issue: Volume:431 Page:96-104
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Xiaogang^ORCID,Chen Hengyu,Liu Zhiqiang,Ye Zeng,Gou Shanmiao,Wang Chunyou

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2016;Siegel;CA A Cancer J. Clin.,2016

2. Recent progress in pancreatic cancer;Wolfgang;CA A Cancer J. Clin.,2013

3. Phase I clinical trial to determine the feasibility and maximum tolerated dose of panitumumab to standard gemcitabine-based chemoradiation in locally advanced pancreatic cancer;van Zweeden;Clin. Canc. Res.,2015

4. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: long-term outcomes;Calvo;Pancreatology,2013

5. Cancer metastasis: building a framework;Gupta;Cell,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of an endoplasmic reticulum stress-related signature predicting outcomes of gastric adenocarcinoma patients;Frontiers in Genetics;2022-09-06

2. Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt/β-catenin signaling and EMT;Phytochemistry;2022-08

3. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer;Scientific Reports;2022-05-14

4. A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial–mesenchymal transition reversion;Journal of Nanobiotechnology;2022-03-05

5. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling;Theranostics;2022